Chinese Journal of Cancer Research

, Volume 15, Issue 2, pp 136–139 | Cite as

Clinicopathological significance of plap, NSE and WT1 detection in ovarian dysgerminoma

  • Zhao Yong 
  • Li Yuan-yuan 
  • Xu Yuan-hao 


Objective: To evaluate the expression of placental alkaline phosphatase (PLAP), neuron-specific enolase (NSE), prolactin (PRL) and Wilms’ tumor gene (WT1) protein in ovarian dysgerminoma and its Clinico-pathological significance. Methods: Clinicopathological data were retrospectively reviewed in a total of 31 patients with pure dysgerminoma who were treated at College Clinical Medicin, Chongqing Medical University from January 1983 to October 2002. Immunohistological staining for PLAP, NSE, PRL and WT1 was performed in all 31 tumor tissues. Results: The age of the patients ranged from 12 to 42 years old (average 25 yrs). According to the clinical staging, eighteen patients (58.1%) had stage I disease, 5 (16.1%) had stage II, 6(19.4%) had stage III, and 2 (6.4%) had stage IV disease. Of the 31 cases, the positive expression rates of PLAP, NSE, PRL and WT1 were 100% (31/31), 70.9%(22/31), 3.2%(1/31) and 12.9(4/31) respectively. There was a significant relation between NSE expression and clinical stages (P<0.05) and 5 years survival rate (P<0.05). The positive expression rate of WT1 was significantly related to histological types (P<0.05). Conclusion: Dysgerminomas in earlier stages (stage I/II) are associated with a favorable prognosis. NSE positive expression is closely related with advanced tumor stage (stage III/IV). PLAP and NSE can be considered as important markers of dysgerminoma tissues, and the tumor tissues are the main resources of serum PLAP and NSE. WT1 expression correlates with poorer differentiation of dysgerminoma. The importance of PRL in dygerminoma was not certified in this study, and remains to be defined.

Key words

Ovary neoplasms Dysgerminoma Tumor biomarkers Pathology 

CLC number



Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Burke AP, Mostofi FK. Placental alkaline phosphatase immunohistochemistry of intratubular malignant germ cells and associated testicular germ cell tumors[J]. Hum Pathol 1988; 19: 663–70.PubMedCrossRefGoogle Scholar
  2. [2]
    Kawata M, Sekiya S, hatakeyama R, et al. Neuron-specific enolase as a serum marker for immature teratoma and dysgerminoma[J]. Gynecol Oncol 1989; 32: 191–7.PubMedCrossRefGoogle Scholar
  3. [3]
    Fossa SD, Klepp O, Paus E. Neuron-specific enolase-a serum tumor marker in seminoma[J]? Br J Cancer 1992; 65: 297–9.PubMedGoogle Scholar
  4. [4]
    Yoshida M, Koshiyama M, Konishi M, et al. Ovarian dysgerminoma showing high serum levels and positive immunostaining of placental alkaline phosphatase and neuron-specific enolase associated with elevation of serum prolactin levelfJ]. Eur J Obstet Gynecol Reprod Biol 1998; 81: 123–8.PubMedCrossRefGoogle Scholar
  5. [5]
    Hustin J, Gillerot Y, Collette J, et al. Placental alkaline phosphatase in developing normal and abnormal gonads and in germ-cell tumors[J]. Virchows Arch A Pathol Anat Histopathol 1990; 417: 67–72.PubMedCrossRefGoogle Scholar
  6. [6]
    Melo KF, Martin RM, Costa EM, et al. An unusual phenotype of Frasier syndrome due to IVS9 + 4 C>T mutation in the WT1 gene: predominantly male ambiguous genitalia and absernce of gonadal dysgenesis[J]. J Clin Endocrinol Metab 2002; 87: 2500–5.PubMedCrossRefGoogle Scholar
  7. [7]
    Barbaux S, Niaudet P, Gubler MC, et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome[J]. Nat Genet 1997; 17: 467–70.PubMedCrossRefGoogle Scholar
  8. [8]
    Little M, Holmes G, Bickmore W, et al. DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome WT1 point mutations[J]. Hum Mol Genet 1995; 4: 351–8.PubMedCrossRefGoogle Scholar
  9. [9]
    Hussong J, Crussi FG, chou PM. Gonadoblastoma: immunohistochemical localization of Mullerian-inhibiting substance, inhibin, WT1, and p53[J]. Mod-Pathol 1997; 10: 1101–5.PubMedGoogle Scholar

Copyright information

© Chinese Journal of Cancer Research 2003

Authors and Affiliations

  1. 1.Department of PathologyChongqing Medical UniversityChongqing

Personalised recommendations